A298060 Share Price Performance
₩1,054.00
-1241.00 (-54.07%)
Price ₩1,054.00
Share Price₩1,054.00
A298060 Community Narratives
There are no narratives available yet.
Recent A298060 News & Updates
No updates
SCM Lifescience Co., Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -326.76
- Gross Margin
- 34.92%
- Net Profit Margin
- -914.17%
- Debt/Equity Ratio
- 32.9%
SCM Lifescience Co., Ltd. Competitors
About A298060
- Founded
- 2014
- Employees
- n/a
- CEO
- WebsiteView website
SCM Lifescience Co., Ltd. operates in the stem cell therapy, CMO, contract research and consulting, and cosmetic businesses. The company develops allogeneic stem cell therapeutics using its stem cell isolation technology and conducting clinical trials for immunological conditions and tissue regeneration; provides CMO services for manufacturing control and quality assurance tests; and offers adult stem cell research services. It also provides skin cell science services. The company was founded in 2014 and is headquartered in Incheon, South Korea.
South Korean Market Performance
- 7 Days: -1.6%
- 3 Months: 21.9%
- 1 Year: 21.3%
- Year to Date: 30.7%
Over the last 7 days, the market has dropped 1.6%, driven by a pullback of 3.6% in the Information Technology sector. In the last year, the market is actually up 21%. Looking forward, earnings are forecast to grow by 22% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading